211 related articles for article (PubMed ID: 8604269)
1. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
[TBL] [Abstract][Full Text] [Related]
2. Changes in the epidemiology of thalassemia in North America: a new minority disease.
Vichinsky EP; MacKlin EA; Waye JS; Lorey F; Olivieri NF
Pediatrics; 2005 Dec; 116(6):e818-25. PubMed ID: 16291734
[TBL] [Abstract][Full Text] [Related]
3. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
Bradai M; Pissard S; Abad MT; Dechartres A; Ribeil JA; Landais P; de Montalembert M
Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major.
Sharma N; Das R; Kaur J; Ahluwalia J; Trehan A; Bansal D; Panigrahi I; Marwaha RK
Eur J Haematol; 2010 Jun; 84(6):531-7. PubMed ID: 20132300
[TBL] [Abstract][Full Text] [Related]
5. Thalassemia major in Connecticut: a 20-year study of changing age distribution and survival.
Pearson HA; Rink L; Guiliotis DK
Conn Med; 1994 May; 58(5):259-60. PubMed ID: 8076456
[TBL] [Abstract][Full Text] [Related]
6. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
7. Beta-thalassemia: the Lebanese experience.
Inati A; Zeineh N; Isma'eel H; Koussa S; Gharzuddine W; Taher A
Clin Lab Haematol; 2006 Aug; 28(4):217-27. PubMed ID: 16898958
[TBL] [Abstract][Full Text] [Related]
8. Patient age distribution in thalassemia major: changes from 1973 to 1985.
Pearson HA; Guiliotis DK; Rink L; Wells JA
Pediatrics; 1987 Jul; 80(1):53-7. PubMed ID: 3601518
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of thalassemia intermedia in Iran.
Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease: the Lebanese experience.
Inati A; Jradi O; Tarabay H; Moallem H; Rachkidi Y; El Accaoui R; Isma'eel H; Wehbe R; Mfarrej BG; Dabbous I; Taher A
Int J Lab Hematol; 2007 Dec; 29(6):399-408. PubMed ID: 17988293
[TBL] [Abstract][Full Text] [Related]
11. Analysis of intelligence quotient in patients with homozygous beta-thalassemia.
Karimi M; Yarmohammadi H; Cappellini MD
Saudi Med J; 2006 Jul; 27(7):982-5. PubMed ID: 16830015
[TBL] [Abstract][Full Text] [Related]
12. [Beta-thalassemia major in children and adolescents in Denmark].
Jung A; Main KM; Scheibel E; Peitersen B; Clausen N; Erichsen G; Schmiegelow K; Illum N
Ugeskr Laeger; 2002 Dec; 164(49):5803-6. PubMed ID: 12523224
[TBL] [Abstract][Full Text] [Related]
13. Serum erythropoietin levels in thalassemia major and intermedia.
Chaisiripoomkere W; Jootar S; Chanjarunee S; Ungkanont A
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):786-8. PubMed ID: 10928378
[TBL] [Abstract][Full Text] [Related]
14. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of fractures among the Thalassemia syndromes in North America.
Vogiatzi MG; Macklin EA; Fung EB; Vichinsky E; Olivieri N; Kwiatkowski J; Cohen A; Neufeld E; Giardina PJ
Bone; 2006 Apr; 38(4):571-5. PubMed ID: 16298178
[TBL] [Abstract][Full Text] [Related]
16. Response to hydroxyurea therapy in beta-thalassemia.
Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
[TBL] [Abstract][Full Text] [Related]
17. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
[TBL] [Abstract][Full Text] [Related]
18. Xmn1-G γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermedia.
Oberoi S; Das R; Panigrahi I; Kaur J; Marwaha RK
Pediatr Blood Cancer; 2011 Dec; 57(6):1025-8. PubMed ID: 21755589
[TBL] [Abstract][Full Text] [Related]
19. Plasma chitotriosidase activity in patients with beta-thalassemia.
Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.
Garewal G; Das R; Ahluwalia J; Marwaha RK; Varma S
Am J Hematol; 2005 Aug; 79(4):252-6. PubMed ID: 16044458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
